Bhavana Bhatnagar
10PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jan 10, 2026
Pharmacologic Targeting of miR29b with Bortezomib and Sorafenib to Improve Decitabine Sensitivity in Patients with Acute Myeloid Leukemia: Results from a Phase 1 Dose-Escalation Trial.Shivani Handa, Kristin Koenig, Qiuhong Zhao
|Jun 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.Eric D Eisenmann, Ronan Swords, Ying Huang
|Oct 30, 2023
Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.Jessica K Altman, Tsila Zuckerman, Jamie Koprivnikar
|Aug 21, 2023
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick
|Nov 11, 2022
Psychological Distress in Young Adults with Acute Myeloid Leukemia Undergoing Induction Chemotherapy.Bethany J Lockwood, Areej El-Jawahri, Alison R Walker
|Jul 07, 2022
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors.Daelynn R Buelow, Bhavana Bhatnagar, Shelley J Orwick
Pageof 2
Frequent Collaborators
5 joint publications
James S Blachly
3 joint publications
Shelley Orwick
2 joint publications
Caner Saygin
2 joint publications
Mitch Phelps
2 joint publications
Alice S Mims
2 joint publications
Daelynn R Buelow
2 joint publications
Eric D Eisenmann
2 joint publications
Sharyn D Baker
1 joint publications
Kristin L Koenig
1 joint publications
Nicole R Grieselhuber
